Literature DB >> 29144448

Regeneration of the entire human epidermis using transgenic stem cells.

Tobias Hirsch1, Tobias Rothoeft2, Norbert Teig2, Johann W Bauer3, Graziella Pellegrini4,5, Laura De Rosa5, Davide Scaglione6, Julia Reichelt3, Alfred Klausegger3, Daniela Kneisz3, Oriana Romano7, Alessia Secone Seconetti5, Roberta Contin5, Elena Enzo5, Irena Jurman8, Sonia Carulli9, Frank Jacobsen1, Thomas Luecke10, Marcus Lehnhardt1, Meike Fischer2, Maximilian Kueckelhaus1, Daniela Quaglino7, Michele Morgante8, Silvio Bicciato7, Sergio Bondanza9, Michele De Luca5.   

Abstract

Junctional epidermolysis bullosa (JEB) is a severe and often lethal genetic disease caused by mutations in genes encoding the basement membrane component laminin-332. Surviving patients with JEB develop chronic wounds to the skin and mucosa, which impair their quality of life and lead to skin cancer. Here we show that autologous transgenic keratinocyte cultures regenerated an entire, fully functional epidermis on a seven-year-old child suffering from a devastating, life-threatening form of JEB. The proviral integration pattern was maintained in vivo and epidermal renewal did not cause any clonal selection. Clonal tracing showed that the human epidermis is sustained not by equipotent progenitors, but by a limited number of long-lived stem cells, detected as holoclones, that can extensively self-renew in vitro and in vivo and produce progenitors that replenish terminally differentiated keratinocytes. This study provides a blueprint that can be applied to other stem cell-mediated combined ex vivo cell and gene therapies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29144448      PMCID: PMC6283270          DOI: 10.1038/nature24487

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  38 in total

1.  Long-term regeneration of human epidermis on third degree burns transplanted with autologous cultured epithelium grown on a fibrin matrix.

Authors:  V Ronfard; J M Rives; Y Neveux; H Carsin; Y Barrandon
Journal:  Transplantation       Date:  2000-12-15       Impact factor: 4.939

2.  A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.

Authors:  Salima Hacein-Bey-Abina; Christof von Kalle; Manfred Schmidt; Françoise Le Deist; Nicolas Wulffraat; Elisabeth McIntyre; Isabelle Radford; Jean-Luc Villeval; Christopher C Fraser; Marina Cavazzana-Calvo; Alain Fischer
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

Review 3.  Regeneration of squamous epithelia from stem cells of cultured grafts.

Authors:  Michele De Luca; Graziella Pellegrini; Howard Green
Journal:  Regen Med       Date:  2006-01       Impact factor: 3.806

4.  Cause-specific risks of childhood death in inherited epidermolysis bullosa.

Authors:  Jo-David Fine; Lorraine B Johnson; Madeline Weiner; Chirayath Suchindran
Journal:  J Pediatr       Date:  2007-10-22       Impact factor: 4.406

5.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.

Authors:  Salima Hacein-Bey-Abina; Alexandrine Garrigue; Gary P Wang; Jean Soulier; Annick Lim; Estelle Morillon; Emmanuelle Clappier; Laure Caccavelli; Eric Delabesse; Kheira Beldjord; Vahid Asnafi; Elizabeth MacIntyre; Liliane Dal Cortivo; Isabelle Radford; Nicole Brousse; François Sigaux; Despina Moshous; Julia Hauer; Arndt Borkhardt; Bernd H Belohradsky; Uwe Wintergerst; Maria C Velez; Lily Leiva; Ricardo Sorensen; Nicolas Wulffraat; Stéphane Blanche; Frederic D Bushman; Alain Fischer; Marina Cavazzana-Calvo
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

6.  Treatment of "stable" vitiligo by Timedsurgery and transplantation of cultured epidermal autografts.

Authors:  L Guerra; S Capurro; F Melchi; G Primavera; S Bondanza; R Cancedda; A Luci; M De Luca; G Pellegrini
Journal:  Arch Dermatol       Date:  2000-11

7.  A single type of progenitor cell maintains normal epidermis.

Authors:  Elizabeth Clayton; David P Doupé; Allon M Klein; Douglas J Winton; Benjamin D Simons; Philip H Jones
Journal:  Nature       Date:  2007-02-28       Impact factor: 49.962

8.  Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells.

Authors:  Fulvio Mavilio; Graziella Pellegrini; Stefano Ferrari; Francesca Di Nunzio; Enzo Di Iorio; Alessandra Recchia; Giulietta Maruggi; Giuliana Ferrari; Elena Provasi; Chiara Bonini; Sergio Capurro; Andrea Conti; Cristina Magnoni; Alberto Giannetti; Michele De Luca
Journal:  Nat Med       Date:  2006-11-19       Impact factor: 53.440

9.  The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin.

Authors:  G Pellegrini; R Ranno; G Stracuzzi; S Bondanza; L Guerra; G Zambruno; G Micali; M De Luca
Journal:  Transplantation       Date:  1999-09-27       Impact factor: 4.939

10.  Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface.

Authors:  G Pellegrini; O Golisano; P Paterna; A Lambiase; S Bonini; P Rama; M De Luca
Journal:  J Cell Biol       Date:  1999-05-17       Impact factor: 10.539

View more
  185 in total

1.  Biomimetics of the pulmonary environment in vitro: A microfluidics perspective.

Authors:  Janna Tenenbaum-Katan; Arbel Artzy-Schnirman; Rami Fishler; Netanel Korin; Josué Sznitman
Journal:  Biomicrofluidics       Date:  2018-05-29       Impact factor: 2.800

2.  The Skin(ny) on Regenerating the Largest Organ to Save a Patient's Life.

Authors:  Rui Yi
Journal:  Cell Stem Cell       Date:  2018-01-04       Impact factor: 24.633

3.  Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa.

Authors:  Su M Lwin; Farhatullah Syed; Wei-Li Di; Tendai Kadiyirire; Lu Liu; Alyson Guy; Anastasia Petrova; Alya Abdul-Wahab; Fiona Reid; Rachel Phillips; Maria Elstad; Christos Georgiadis; Sophia Aristodemou; Patricia A Lovell; James R McMillan; John Mee; Snaigune Miskinyte; Matthias Titeux; Linda Ozoemena; Rashida Pramanik; Sonia Serrano; Racheal Rowles; Clarisse Maurin; Elizabeth Orrin; Magdalena Martinez-Queipo; Ellie Rashidghamat; Christos Tziotzios; Alexandros Onoufriadis; Mei Chen; Lucas Chan; Farzin Farzaneh; Marcela Del Rio; Jakub Tolar; Johann W Bauer; Fernando Larcher; Michael N Antoniou; Alain Hovnanian; Adrian J Thrasher; Jemima E Mellerio; Waseem Qasim; John A McGrath
Journal:  JCI Insight       Date:  2019-06-06

Review 4.  Applied Bioengineering in Tissue Reconstruction, Replacement, and Regeneration.

Authors:  Juan M Colazo; Brian C Evans; Angel F Farinas; Salam Al-Kassis; Craig L Duvall; Wesley P Thayer
Journal:  Tissue Eng Part B Rev       Date:  2019-08       Impact factor: 6.389

Review 5.  Next-generation stem cells - ushering in a new era of cell-based therapies.

Authors:  Erin A Kimbrel; Robert Lanza
Journal:  Nat Rev Drug Discov       Date:  2020-04-06       Impact factor: 84.694

Review 6.  Model organism data evolving in support of translational medicine.

Authors:  Douglas G Howe; Judith A Blake; Yvonne M Bradford; Carol J Bult; Brian R Calvi; Stacia R Engel; James A Kadin; Thomas C Kaufman; Ranjana Kishore; Stanley J F Laulederkind; Suzanna E Lewis; Sierra A T Moxon; Joel E Richardson; Cynthia Smith
Journal:  Lab Anim (NY)       Date:  2018-09-17       Impact factor: 12.625

7.  CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient.

Authors:  Daniela Benati; Francesca Miselli; Fabienne Cocchiarella; Clarissa Patrizi; Marta Carretero; Samantha Baldassarri; Virginia Ammendola; Cristina Has; Stefano Colloca; Marcela Del Rio; Fernando Larcher; Alessandra Recchia
Journal:  Mol Ther       Date:  2018-08-04       Impact factor: 11.454

8.  Translation regulation in skin cancer from a tRNA point of view.

Authors:  Katerina Grafanaki; Dimitrios Anastasakis; George Kyriakopoulos; Ilias Skeparnias; Sophia Georgiou; Constantinos Stathopoulos
Journal:  Epigenomics       Date:  2018-12-19       Impact factor: 4.778

Review 9.  Profiling Immune Expression to Consider Repurposing Therapeutics for the Ichthyoses.

Authors:  Amy S Paller
Journal:  J Invest Dermatol       Date:  2019-01-19       Impact factor: 8.551

10.  Development of a Peptide Derived from Platelet-Derived Growth Factor (PDGF-BB) into a Potential Drug Candidate for the Treatment of Wounds.

Authors:  Milena Deptuła; Przemysław Karpowicz; Anna Wardowska; Piotr Sass; Paweł Sosnowski; Alina Mieczkowska; Natalia Filipowicz; Maria Dzierżyńska; Justyna Sawicka; Ewa Nowicka; Paulina Langa; Adriana Schumacher; Mirosława Cichorek; Jacek Zieliński; Karolina Kondej; Franciszek Kasprzykowski; Artur Czupryn; Łukasz Janus; Piotr Mucha; Piotr Skowron; Arkadiusz Piotrowski; Paweł Sachadyn; Sylwia Rodziewicz-Motowidło; Michał Pikuła
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-10-29       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.